HK shares end lower as tech stocks weigh on fears of e-commerce price war

Reuters
Yesterday
HK shares end lower as tech stocks weigh on fears of e-commerce price war

Updates to market close

SHANGHAI, July 3 (Reuters) - Hong Kong shares closed down on Thursday, led by tech stocks, as investors fretted that intensifying competition among e-commerce giants could squeeze profit margins.

China stocks ended higher.

** China's blue-chip CSI300 Index .CSI300 closed up 0.6%, while the Shanghai Composite Index .SSEC was 0.2% higher. Hong Kong benchmark Hang Seng .HSI was down 0.6%.

** E-commerce giant Alibaba 9988.HK shares listed in Hong Kong fell nearly 3%, leading declines in Hong Kong, after the company announced a 50-billion-yuan ($6.98 billion) subsidy programme to merchants and customers on Wednesday.

** "Alibaba's plan to offer $7 bn of subsidies for food delivery and online retail implies competition is heating up again among China e-commerce companies," said UBS analysts.

** Shares of on-demand delivery giant Meituan 3690.HK dropped 2.5%, while JD.com 9618.HK fell 2.1%.

** Meanwhile, a prominent Chinese Communist Party publication called for a crackdown on competition that fuels price wars and squeezes profits in various industries, criticising large companies and local governments for unfair practices.

** China's services activity expanded at the slowest pace in nine months in June, as demand weakened and new export orders declined amid a fragile trade truce with the United States, a private sector survey showed on Thursday.

** China's semiconductor shares .CSIH30184 were little moved after U.S. chip design software developers said they have received notices lifting restrictions on exports to China.

** China is assessing the trade deal between the United States and Vietnam, and will safeguard its own rights and interests if needed, a spokesperson for China's commerce ministry said on Thursday.

** Healthcare shares .CSIHCSI led gains onshore, up 1.2%, as Beijing ramped up policy support for the country's innovative drugs.

** Biotech stocks also rose in Hong Kong, with Ascentage 6855.HK up 6.2%.

($1 = 7.1643 Chinese yuan renminbi)

(Reporting by Shanghai Newsroom; Editing by Vijay Kishore)

((li.gu@tr.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10